IFPA Welcomes New Regional Collaboration to Strengthen Care for Psoriatic Disease Across Latin America

The International Federation of Psoriasis Associations (IFPA) welcomes the launch of a new regional collaboration bringing together the International Psoriasis Council (IPC), Pan American League of Associations for Rheumatology (PANLAR), Latin American Society of Psoriasis and Dermoimmunology (SOLAPSO), and the Latin American Coalition of Immune-Mediated Skin Diseases (COLAPPIEL) to improve care for people living with psoriasis and psoriatic arthritis across Latin America.

The collaboration was formally introduced during a joint symposium at the PANLAR Congress in Panama City, convening dermatologists, rheumatologists, and patient leaders. The purpose of this collaboration is to address persistent challenges that people living with psoriatic disease face, including delayed diagnosis, fragmented care, and unequal access to treatment across the region.

For people living with psoriatic disease, these challenges are real. They shape daily life, limit access to appropriate care, and contribute to preventable physical, emotional, and social consequences. IFPA has long emphasized that improving outcomes requires not only clinical excellence, but also strong coordination across specialties and meaningful inclusion of the patient voice.

“This collaboration reflects exactly the direction psoriatic disease care must take,” said Ingvar Ingvarsson, President of the International Federation of Psoriasis Associations (IFPA). “When clinicians, scientific leaders, and patient organizations work together across borders and disciplines, we move closer to care that is earlier, more coordinated, and more responsive to the realities patients face every day.”

IFPA views this initiative as a critical step toward more integrated, patient-centered models of care in the region, and as a strong example of how scientific societies and patient organizations can work together to drive change for the psoriatic community.

“As a global federation of national patient organizations, IFPA’s role is to ensure that the lived experience of people with psoriasis and psoriatic arthritis informs policy, practice, and research,” added Ingvar Ingvarsson. “This collaboration strengthens that commitment and creates a platform for long-term impact across Latin America.”